公开(公告)号：US11891359B2

公开(公告)日：2024-02-06

申请号：US17955922

申请日：2022-09-29

Applicant: ENVERIC BIOSCIENCES CANADA INC.

Inventor： Jillian M. Hagel ,  Peter J. Facchini ,  Xue Chen

IPC: C07D209/16

CPC classification number: C07D209/16

Abstract: Disclosed are novel prenylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced in vitro or in vivo using a biosynthetic system which comprises cells comprising a prenyl transferase, and, optionally, additional enzymes, including a decarboxylase, and an N-acetyl transferase.

公开(公告)号：US20230219888A1

公开(公告)日：2023-07-13

申请号：US17955922

申请日：2022-09-29

Applicant: ENVERIC BIOSCIENCES CANADA INC.

Inventor： Jillian M. Hagel ,  Peter J. Facchini ,  Xue Chen

IPC: C07D209/16

CPC classification number: C07D209/16

Abstract: Disclosed are novel prenylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced in vitro or in vivo using a biosynthetic system which comprises cells comprising a prenyl transferase, and, optionally, additional enzymes, including a decarboxylase, and an N-acetyl transferase.